Outcome
    Moderate Evidence

    Probiotics for Respiratory Tract Protection

    Probiotics modestly reduce the number and duration of upper respiratory infections.

    Overview

    The best-studied use of probiotics outside the gut is reducing how often people catch upper respiratory infections. Cochrane reviewers found fewer episodes, shorter illness and less antibiotic use with daily probiotics compared with placebo, while rating the certainty of that evidence as low. That combination, consistent direction with modest quality, is exactly what a likely verdict is meant to describe. Expect a smaller share of the winter colds, not immunity.

    What the evidence supports

    Fewer and shorter acute upper respiratory infections with continuous daily use, on low-certainty evidence.

    How It Works

    Gut-resident lactobacilli and bifidobacteria interact with dendritic cells in gut-associated lymphoid tissue, shifting cytokine output and raising secretory IgA at distant mucosal surfaces, including the airway, through what is often called the gut-lung axis.
    This is immune modulation rather than antiviral action. Nothing in the mechanism suggests protection once an infection is established, which fits the trial finding that the effect is preventive.

    Dosing & Protocol

    Trials dosed daily across an entire respiratory season. Start before the season rather than at the first symptom, and keep the strain consistent.

    Start early

    Begin several weeks before your usual high-risk season; the benefit accrues over months of continuous dosing.

    Evidence

    Both linked records are Cochrane analyses of probiotics for preventing acute upper respiratory tract infection, covering episode counts and illness duration.

    Probiotics for preventing acute upper respiratory tract infections

    Score: 7/10
    2015
    systematic_review
    n=3720

    Hao Q, Dong BR, Wu T

    Probiotics reduced the number of participants experiencing acute upper respiratory infections

    View source

    Probiotics for preventing acute upper respiratory tract infections

    Score: 8/10
    2015
    systematic_review
    n=3720

    Hao Q, Dong BR, Wu T

    Probiotics were better than placebo in reducing the number of participants experiencing episodes of acute upper respiratory tract infection.

    View source
    The reviewers repeatedly flag small trials, mixed strains and inconsistent blinding. The effect survives those caveats but should be read as an average across populations, not a personal guarantee.

    Safety

    Side effects are usually limited to short-lived bloating or wind in the first week. Anyone significantly immunocompromised, critically ill, or with a central line should not start probiotics without medical supervision.

    See a clinician if symptoms escalate

    Breathlessness, high fever or symptoms lasting beyond ten days need medical assessment, not a supplement adjustment.

    Interactions & Conflicts

    Interacts withSeverityMechanismAction
    —Separate doses by two to three hours
    —Seek medical advice before starting
    —No action needed

    References

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.